Research progress of radiomics toward lung adenocarcinoma manifesting as solitary ground glass nodule

doi:10.3760/cma.j.cn371439-20220303-00087

Abstract

Abstract:

The detection of early lung adenocarcinoma manifesting as ground glass nodule （GGN） is increasing. The promoting precision targeted therapy arises the need of radiomics （RM） and radiogenomics, a series of noninvasively radiological technology based on multiple modality, to assist the process including determination in diagnosis, treatment and follow-up strategy and release burden in clinical practice. RM, playing an important role in lung adenocarcinoma manifesting as GGN, can provide information towards the different components of the nodules, the analysis of peritumoral areas, the reduction of over diagnosis and treatment, the selection of targeted therapy and follow-up.

Key words: Carcinoma, non-small-cell lung, Ground glass nodules, Radiomics, Tumor heterogeneity, Tumor microenvironment

Wu Jiayu, Liu Jiacheng. Research progress of radiomics toward lung adenocarcinoma manifesting as solitary ground glass nodule[J]. Journal of International Oncology, 2022, 49(8): 449-452.

References 28

[1]	Succony L, Rassl DM, Barker AP, et al. Adenocarcinoma spectrum lesions of the lung: detection, pathology and treatment strategies[J]. Cancer Treat Rev, 2021, 99: 102237. DOI: 10.1016/j.ctrv.2021.102237. doi: 10.1016/j.ctrv.2021.102237
[2]	Sung H, Ferlay J, Siegel RL, et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries[J]. CA Cancer J Clin, 2021, 71(3): 209-249. DOI: 10.3322/caac.21660. doi: 10.3322/caac.21660
[3]	Xiong Z, Jiang Y, Che S, et al. Use of CT radiomics to differentiate minimally invasive adenocarcinomas and invasive adenocarcinomas presenting as pure ground-glass nodules larger than 10 mm[J]. Eur J Radiol, 2021, 141: 109772. DOI: 10.1016/j.ejrad.2021.109772. doi: 10.1016/j.ejrad.2021.109772
[4]	Shao X, Niu R, Shao X, et al. Value of ¹⁸F-FDG PET/CT-based radiomics model to distinguish the growth patterns of early invasive lung adenocarcinoma manifesting as ground-glass opacity nodules[J]. EJNMMI Res, 2020, 10(1): 80. DOI: 10.1186/s13550-020-00668-4. doi: 10.1186/s13550-020-00668-4
[5]	Gao C, Yan J, Luo Y, et al. The growth trend predictions in pulmonary ground glass nodules based on radiomic CT features[J]. Front Oncol, 2020, 10: 580809. DOI: 10.3389/fonc.2020.580809. doi: 10.3389/fonc.2020.580809
[6]	Niu R, Gao J, Shao X, et al. Maximum standardized uptake value of ¹⁸F-deoxyglucose PET imaging increases the effectiveness of CT radiomics in differentiating benign and malignant pulmonary ground-glass nodules[J]. Front Oncol, 2021, 11: 727094. DOI: 10.3389/fonc.2021.727094. doi: 10.3389/fonc.2021.727094
[7]	Heidinger BH, Anderson KR, Nemec U, et al. Lung adenocarcinoma manifesting as pure ground-glass nodules: correlating CT size, volume, density, and roundness with histopathologic invasion and size[J]. J Thorac Oncol, 2017, 12(8): 1288-1298. DOI: 10.1016/j.jtho.2017.05.017. doi: S1556-0864(17)30425-2 pmid: 28576745
[8]	Azour L, Ko JP, Naidich DP, et al. Shades of gray: subsolid nodule considerations and management[J]. Chest, 2021, 159(5): 2072-2089. DOI: 10.1016/j.chest.2020.09.252. doi: 10.1016/j.chest.2020.09.252
[9]	Wang HJ, Lin MW, Chen YC, et al. A radiomics model can distinguish solitary pulmonary capillary haemangioma from lung adenocarcinoma[J]. Interact Cardiovasc Thorac Surg, 2022, 34(3): 369-377. DOI: 10.1093/icvts/ivab271. doi: 10.1093/icvts/ivab271
[10]	Sun Y, Li C, Jin L, et al. Radiomics for lung adenocarcinoma manifesting as pure ground-glass nodules: invasive prediction[J]. Eur Radiol, 2020, 30(7): 3650-3659. DOI: 10.1007/s00330-020-06776-y. doi: 10.1007/s00330-020-06776-y
[11]	Wu L, Gao C, Ye J, et al. The value of various peritumoral radiomic features in differentiating the invasiveness of adenocarci-noma manifesting as ground-glass nodules[J]. Eur Radiol, 2021, 31(12): 9030-9037. DOI: 10.1007/s00330-021-07948-0. doi: 10.1007/s00330-021-07948-0
[12]	Meng F, Guo Y, Li M, et al. Radiomics nomogram: a noninvasive tool for preoperative evaluation of the invasiveness of pulmonary adenocarcinomas manifesting as ground-glass nodules[J]. Transl Oncol, 2021, 14(1): 100936. DOI: 10.1016/j.tranon.2020.100936. doi: 10.1016/j.tranon.2020.100936
[13]	Wu G, Woodruff HC, Shen J, et al. Diagnosis of invasive lung adenocarcinoma based on chest CT radiomic features of part-solid pulmonary nodules: a multicenter study[J]. Radiology, 2020, 297(2): 451-458. DOI: 10.1148/radiol.2020192431. doi: 10.1148/radiol.2020192431
[14]	Cai J, Liu H, Yuan H, et al. A radiomics study to predict invasive pulmonary adenocarcinoma appearing as pure ground-glass nodules[J]. Clin Radiol, 2021, 76(2): 143-151. DOI: 10.1016/j.crad.2020.10.005. doi: 10.1016/j.crad.2020.10.005 pmid: 33187676
[15]	Yang X, Dong X, Wang J, et al. Computed tomography-based radiomics signature: a potential indicator of epidermal growth factor receptor mutation in pulmonary adenocarcinoma appearing as a subsolid nodule[J]. Oncologist, 2019, 24(11): e1156-e1164. DOI: 10.1634/theoncologist.2018-0706. doi: 10.1634/theoncologist.2018-0706
[16]	Shi L, Shi W, Peng X, et al. Development and validation a nomogram incorporating CT radiomics signatures and radiological features for differentiating invasive adenocarcinoma from adenocarcinoma in situ and minimally invasive adenocarcinoma presenting as ground-glass nodules measuring 5-10mm in diameter[J]. Front Oncol, 2021, 11: 618677. DOI: 10.3389/fonc.2021.618677. doi: 10.3389/fonc.2021.618677
[17]	Ma Y, Ma W, Xu X, et al. How does the delta-radiomics better differentiate pre-invasive GGNs from invasive GGNs?[J]. Front Oncol, 2020, 10: 1017. DOI: 10.3389/fonc.2020.01017. doi: 10.3389/fonc.2020.01017
[18]	Song L, Xing T, Zhu Z, et al. Hybrid clinical-radiomics model for precisely predicting the invasiveness of lung adenocarcinoma manifesting as pure ground-glass nodule[J]. Acad Radiol, 2021, 28(9): e267-e277. DOI: 10.1016/j.acra.2020.05.004. doi: 10.1016/j.acra.2020.05.004
[19]	Wang B, Tang Y, Chen Y, et al. Joint use of the radiomics method and frozen sections should be considered in the prediction of the final classification of peripheral lung adenocarcinoma manifesting as ground-glass nodules[J]. Lung Cancer, 2020, 139: 103-110. DOI: 10.1016/j.lungcan.2019.10.031. doi: S0169-5002(19)30712-3 pmid: 31760351
[20]	Yan J, Xue X, Gao C, et al. Predicting the Ki-67 proliferation index in pulmonary adenocarcinoma patients presenting with subsolid nodules: construction of a nomogram based on CT images[J]. Quant Imaging Med Surg, 2022, 12(1): 642-652. DOI: 10.21037/qims-20-1385. doi: 10.21037/qims-20-1385
[21]	Li Y, Liu J, Yang X, et al. Prediction of invasive adenocarcinomas manifesting as pure ground-glass nodules based on radiomic signature of low-dose CT in lung cancer screening[J]. Br J Radiol, 2022, 95(1133): 20211048. DOI: 10.1259/bjr.20211048. doi: 10.1259/bjr.20211048
[22]	Jiang Y, Che S, Ma S, et al. Radiomic signature based on CT imaging to distinguish invasive adenocarcinoma from minimally invasive adenocarcinoma in pure ground-glass nodules with pleural contact[J]. Cancer Imaging, 2021, 21(1): 1. DOI: 10.1186/s40644-020-00376-1. doi: 10.1186/s40644-020-00376-1
[23]	Xu F, Zhu W, Shen Y, et al. Radiomic-based quantitative CT analysis of pure ground-glass nodules to predict the invasiveness of lung adenocarcinoma[J]. Front Oncol, 2020, 10: 872. DOI: 10.3389/fonc.2020.00872. doi: 10.3389/fonc.2020.00872
[24]	Chen W, Li M, Mao D, et al. Radiomics signature on CECT as a predictive factor for invasiveness of lung adenocarcinoma manifes-ting as subcentimeter ground glass nodules[J]. Sci Rep, 2021, 11(1): 3633. DOI: 10.1038/s41598-021-83167-3. doi: 10.1038/s41598-021-83167-3
[25]	Cho HH, Lee G, Lee HY, et al. Marginal radiomics features as imaging biomarkers for pathological invasion in lung adenocarcinoma[J]. Eur Radiol, 2020, 30(5): 2984-2994. DOI: 10.1007/s00330-019-06581-2. doi: 10.1007/s00330-019-06581-2
[26]	Gevaert O, Echegaray S, Khuong A, et al. Predictive radiogeno-mics modeling of EGFR mutation status in lung cancer[J]. Sci Rep, 2017, 7: 41674. DOI: 10.1038/srep41674. doi: 10.1038/srep41674
[27]	杨蕾, 张传玉, 张在先, 等. 非小细胞肺癌影像基因组学[J]. 国际肿瘤学杂志, 2020, 47(9): 555-559. DOI: 10.3760/cma.j.cn371439-20200423-00077. doi: 10.3760/cma.j.cn371439-20200423-00077
[28]	Jansen RW, van Amstel P, Martens RM, et al. Non-invasive tumor genotyping using radiogenomic biomarkers, a systematic review and oncology-wide pathway analysis[J]. Oncotarget, 2018, 9(28): 20134-20155. DOI: 10.18632/oncotarget.24893. doi: 10.18632/oncotarget.24893 pmid: 29732009